SLLK, Control Peptide for TSP1 Inhibitor (TFA) is a control peptide for LSKL, which is a Thrombospondin (TSP-1) inhibitor.
CAT No: R1679
SLLK, Control Peptide for TSP1 Inhibitor(TFA), is a synthetic peptide designed to serve as a negative control in studies involving thrombospondin-1 (TSP1) inhibition. As a structurally defined oligopeptide, SLLK lacks the specific biological activity of TSP1-targeting sequences, making it invaluable for distinguishing nonspecific effects from those directly attributable to TSP1 pathway modulation. Its use is particularly relevant in experimental protocols where rigorous validation of TSP1 inhibitor specificity is required, ensuring that observed cellular or biochemical responses are indeed the result of targeted interactions rather than off-target or background effects. The neutral biochemical properties and defined sequence of SLLK facilitate its integration into a range of peptide-based assays and mechanistic studies.
Negative Control in Peptide-Based Assays: In the context of TSP1 inhibition research, SLLK is widely employed as a negative control peptide. Its sequence does not interact with TSP1 or its downstream effectors, enabling researchers to benchmark experimental outcomes against a baseline where the intended inhibitory mechanism is absent. This application is critical for validating the specificity of TSP1 inhibitors and for distinguishing genuine biological responses from artifacts or nonspecific signaling events. By incorporating SLLK alongside active inhibitors, investigators can ensure that assay readouts are attributable to targeted modulation rather than general peptide exposure.
Validation of Experimental Specificity: The use of SLLK supports rigorous specificity testing in both in vitro and cell-based experimental models. When included in parallel with TSP1 inhibitors, SLLK helps confirm that observed phenotypic or molecular changes are not due to sequence-independent effects, such as peptide-induced cytotoxicity, membrane perturbation, or general stress responses. This control function is essential for high-confidence interpretation of data, particularly in studies dissecting complex signaling networks or evaluating the role of TSP1 in cellular processes.
Peptide Structure-Function Analyses: SLLK serves as a reference molecule in structure-function studies aimed at deciphering the critical sequence motifs responsible for TSP1 inhibition. By comparing the biological and biochemical effects of SLLK with those of active TSP1-inhibitory peptides, researchers can delineate the structural requirements for effective inhibition. This comparative approach aids in mapping essential residues, optimizing inhibitor design, and elucidating the molecular interactions underpinning TSP1-related pathways.
Assay Development and Optimization: The inclusion of SLLK in assay development workflows allows for the optimization of experimental conditions by providing a non-reactive baseline. Its predictable lack of activity ensures that assay parameters, such as signal-to-noise ratio and dynamic range, can be accurately assessed. This is particularly important when establishing high-throughput screening platforms or quantitative peptide assays, where robust controls are necessary to minimize false positives and ensure reproducibility.
Quality Control in Peptide Synthesis and Handling: SLLK is also utilized as a benchmark for peptide synthesis quality and handling protocols. Its well-characterized sequence and absence of biological activity make it suitable for validating peptide solubilization, storage stability, and delivery methods in experimental setups. By monitoring the behavior of SLLK under various conditions, researchers can identify and mitigate potential technical issues that might compromise the integrity of more functionally active peptides, thereby enhancing the reliability of peptide-based research applications.
3. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
4. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More